KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 189 filers reported holding KRYSTAL BIOTECH INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $483,836 | +0.1% | 4,171 | +1.3% | 0.02% | 0.0% |
Q2 2023 | $483,453 | -62.5% | 4,118 | -74.4% | 0.02% | -62.8% |
Q1 2023 | $1,289,366 | +1.0% | 16,105 | -0.1% | 0.04% | -21.8% |
Q4 2022 | $1,277,185 | -14.2% | 16,122 | -24.5% | 0.06% | -20.3% |
Q3 2022 | $1,489,000 | +6.5% | 21,358 | +0.3% | 0.07% | +7.8% |
Q2 2022 | $1,398,000 | -14.9% | 21,284 | -13.4% | 0.06% | -1.5% |
Q1 2022 | $1,643,000 | -31.0% | 24,565 | -27.8% | 0.06% | -26.1% |
Q4 2021 | $2,381,000 | +735.4% | 34,036 | +524.1% | 0.09% | +700.0% |
Q3 2021 | $285,000 | -23.2% | 5,454 | 0.0% | 0.01% | -31.2% |
Q2 2021 | $371,000 | -11.7% | 5,454 | 0.0% | 0.02% | -20.0% |
Q1 2021 | $420,000 | +28.4% | 5,454 | 0.0% | 0.02% | +11.1% |
Q4 2020 | $327,000 | +39.1% | 5,454 | 0.0% | 0.02% | +20.0% |
Q3 2020 | $235,000 | +4.4% | 5,454 | 0.0% | 0.02% | 0.0% |
Q2 2020 | $225,000 | – | 5,454 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 895,000 | $68,951,000 | 5.53% |
S Squared Technology, LLC | 85,215 | $6,565,000 | 3.10% |
First Light Asset Management, LLC | 491,511 | $37,866,000 | 2.51% |
Soleus Capital Management, L.P. | 166,844 | $12,854,000 | 2.32% |
Redmile Group, LLC | 2,060,132 | $158,713,000 | 2.24% |
Nicholas Investment Partners, LP | 304,689 | $23,473,000 | 1.64% |
HighMark Wealth Management LLC | 17,192 | $1,324,000 | 1.06% |
DSAM Partners (London) Ltd | 70,274 | $5,414,000 | 1.00% |
Artal Group S.A. | 500,000 | $38,520,000 | 0.68% |
Hood River Capital Management LLC | 237,882 | $18,326,000 | 0.59% |